The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

Russell, 2009, Fifty years of advances in bile acid synthesis and metabolism, J Lipid Res, 50, S120, 10.1194/jlr.R800026-JLR200 Russell, 1992, Bile acid biosynthesis, Biochemistry, 31, 4737, 10.1021/bi00135a001 Inagaki, 2006, Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor, Proc Natl Acad Sci USA, 103, 3920, 10.1073/pnas.0509592103 Houten, 2006, Endocrine functions of bile acids, EMBO J, 25, 1419, 10.1038/sj.emboj.7601049 Thomas, 2008, Targeting bile-acid signalling for metabolic diseases, Nat Rev Drug Discov, 7, 678, 10.1038/nrd2619 Russell, 2003, The enzymes, regulation, and genetics of bile acid synthesis, Annu Rev Biochem, 72, 137, 10.1146/annurev.biochem.72.121801.161712 Ishibashi, 1996, Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation, J Biol Chem, 271, 18017, 10.1074/jbc.271.30.18017 Schwarz, 1996, Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase, J Biol Chem, 271, 18024, 10.1074/jbc.271.30.18024 Kwakye, 1993, Identification of bile acid coenzyme A synthetase in rat kidney, J Lipid Res, 34, 95, 10.1016/S0022-2275(20)41323-9 Falany, 1994, Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA: amino acid N-acyltransferase, J Biol Chem, 269, 19375, 10.1016/S0021-9258(17)32178-6 Hubbard, 2006, Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity, Gastroenterology, 130, 1259, 10.1053/j.gastro.2006.02.012 Kalaany, 2006, LXRS and FXR: the yin and yang of cholesterol and fat metabolism, Annu Rev Physiol, 68, 159, 10.1146/annurev.physiol.68.033104.152158 Bensinger, 2008, Integration of metabolism and inflammation by lipid-activated nuclear receptors, Nature, 454, 470, 10.1038/nature07202 Chen, 2007, Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice, Cell Metab, 5, 73, 10.1016/j.cmet.2006.11.012 Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha, Cell, 93, 693, 10.1016/S0092-8674(00)81432-4 Goodwin, 2000, SHP-1, and LRH-1 represses bile acid biosynthesis, Mol Cell, 6, 517, 10.1016/S1097-2765(00)00051-4 Lu, 2000, Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors, Mol Cell, 6, 507, 10.1016/S1097-2765(00)00050-2 Brendel, 2002, The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity, Mol Endocrinol, 16, 2065, 10.1210/me.2001-0194 Stroup, 1997, Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A, Am J Physiol, 273, G508 De Fabiani, 2001, J Biol Chem, 276, 30708, 10.1074/jbc.M103270200 Zhang, 2001, Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression, J Biol Chem, 276, 41690, 10.1074/jbc.M105117200 del Castillo-Olivares, 2000, Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription, J Biol Chem, 275, 17793, 10.1074/jbc.M000996200 Mataki, 2007, Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1, Mol Cell Biol, 27, 8330, 10.1128/MCB.00852-07 Lee, 2008, Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis, Mol Endocrinol, 22, 1345, 10.1210/me.2007-0565 Inagaki, 2005, Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis, Cell Metab, 2, 217, 10.1016/j.cmet.2005.09.001 Lin, 2007, Liver-specific activities of FGF19 require Klotho beta, J Biol Chem, 282, 27277, 10.1074/jbc.M704244200 Choi, 2006, Identification of a hormonal basis for gallbladder filling, Nat Med, 12, 1253, 10.1038/nm1501 Houten, 2004, The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts, Ann Med, 36, 482, 10.1080/07853890410018790 Schiff, 1972, Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat, J Clin Invest, 51, 1351, 10.1172/JCI106931 Oelkers, 1997, Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2), J Clin Invest, 99, 1880, 10.1172/JCI119355 Houten, 2007, In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue, Mol Endocrinol, 21, 1312, 10.1210/me.2007-0113 Kullak-Ublick, 2004, Enterohepatic bile salt transporters in normal physiology and liver disease, Gastroenterology, 126, 322, 10.1053/j.gastro.2003.06.005 Wagner, 2009, New molecular insights into the mechanisms of cholestasis, J Hepatol, 51, 565, 10.1016/j.jhep.2009.05.012 Seol, 1995, Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors, Mol Endocrinol, 9, 72 Forman, 1995, Identification of a nuclear receptor that is activated by farnesol metabolites, Cell, 81, 687, 10.1016/0092-8674(95)90530-8 Makishima, 1999, Identification of a nuclear receptor for bile acids, Science, 284, 1362, 10.1126/science.284.5418.1362 Parks, 1999, Bile acids: natural ligands for an orphan nuclear receptor, Science, 284, 1365, 10.1126/science.284.5418.1365 Wang, 1999, Endogenous bile acids are ligands for the nuclear receptor FXR/BAR, Mol Cell, 3, 543, 10.1016/S1097-2765(00)80348-2 Otte, 2003, Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol, Mol Cell Biol, 23, 864, 10.1128/MCB.23.3.864-872.2003 Xie, 2001, An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids, Proc Natl Acad Sci USA, 98, 3375, 10.1073/pnas.051014398 Staudinger, 2001, The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity, Proc Natl Acad Sci USA, 98, 3369, 10.1073/pnas.051551698 Makishima, 2002, Vitamin D receptor as an intestinal bile acid sensor, Science, 296, 1313, 10.1126/science.1070477 Goodwin, 2003, Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor, Proc Natl Acad Sci USA, 100, 223, 10.1073/pnas.0237082100 Gascon-Barre, 2003, The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells, Hepatology, 37, 1034, 10.1053/jhep.2003.50176 Schmidt, 2010, Regulation of bile acid synthesis by fat-soluble vitamins A and D, J Biol Chem, 10.1074/jbc.M110.116004 Li, 2005, Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription, Am J Physiol Gastrointest Liver Physiol, 288, G74, 10.1152/ajpgi.00258.2004 Gupta, 2001, Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway, J Biol Chem, 276, 15816, 10.1074/jbc.M010878200 Holt, 2003, Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis, Genes Dev, 17, 1581, 10.1101/gad.1083503 Qiao, 2001, Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis, Carcinogenesis, 22, 35, 10.1093/carcin/22.1.35 Dent, 2005, Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes, Hepatology, 42, 1291, 10.1002/hep.20942 Qiao, 2003, Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes, Mol Cell Biol, 23, 3052, 10.1128/MCB.23.9.3052-3066.2003 Goldberg, 2010, Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes, Aging (Albany NY), 2, 393, 10.18632/aging.100168 Pierce, 2002, Seven-transmembrane receptors, Nat Rev Mol Cell Biol, 3, 639, 10.1038/nrm908 Raufman, 1998, Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from guinea pig stomach, Am J Physiol, 274, G997 Raufman, 2002, Deoxycholic acid conjugates are muscarinic cholinergic receptor antagonists, Pharmacology, 65, 215, 10.1159/000064347 Le, 2002, Formyl-peptide receptors revisited, Trends Immunol, 23, 541, 10.1016/S1471-4906(02)02316-5 Ferrari, 2006, Pharmacophore model for bile acids recognition by the FPR receptor, J Comput Aided Mol Des, 20, 295, 10.1007/s10822-006-9055-1 Chen, 2000, Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors, Inflamm Res, 49, 744, 10.1007/s000110050656 Wess, 2007, Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development, Nat Rev Drug Discov, 6, 721, 10.1038/nrd2379 Gautam, 2006, A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo, Cell Metab, 3, 449, 10.1016/j.cmet.2006.04.009 Maruyama, 2002, Identification of membrane-type receptor for bile acids (M-BAR), Biochem Biophys Res Commun, 298, 714, 10.1016/S0006-291X(02)02550-0 Kawamata, 2003, A G protein-coupled receptor responsive to bile acids, J Biol Chem, 278, 9435, 10.1074/jbc.M209706200 Herbert, 2010, Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5, Bioorg Med Chem Lett, 20, 5718, 10.1016/j.bmcl.2010.08.014 Vassileva, 2006, Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation, Biochem J, 398, 423, 10.1042/BJ20060537 Keitel, 2009, The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders, Hepatology, 50, 861, 10.1002/hep.23032 Maruyama, 2006, Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice, J Endocrinol, 191, 197, 10.1677/joe.1.06546 Keitel, 2007, The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells, Hepatology, 45, 695, 10.1002/hep.21458 Keitel, 2008, Expression and function of the bile acid receptor TGR5 in Kupffer cells, Biochem Biophys Res Commun, 372, 78, 10.1016/j.bbrc.2008.04.171 Watanabe, 2006, Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation, Nature, 439, 484, 10.1038/nature04330 Poole, 2010, Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system, Neurogastroenterol Motil, 10.1111/j.1365-2982.2010.01487.x Thomas, 2009, TGR5-mediated bile acid sensing controls glucose homeostasis, Cell Metab, 10, 167, 10.1016/j.cmet.2009.08.001 Vassileva, 2010, Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice, J Endocrinol, 10.1677/JOE-10-0009 Lavoie, 2010, Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels, J Physiol, 10.1113/jphysiol.2010.192146 Keitel, 2010, The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes, Biol Chem, 391, 785, 10.1515/bc.2010.077 Brufau, 2010, Plasma bile acids are not associated with energy metabolism in humans, Nutr Metab (Lond), 7, 73, 10.1186/1743-7075-7-73 Shaham, 2008, Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity, Mol Syst Biol, 4, 214, 10.1038/msb.2008.50 Patti, 2009, Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism, Obesity (Silver Spring), 17, 1671, 10.1038/oby.2009.102 Thomas, 2008, Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism, Thyroid, 18, 167, 10.1089/thy.2007.0255 Katsuma, 2005, Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1, Biochem Biophys Res Commun, 329, 386, 10.1016/j.bbrc.2005.01.139 Tolessa, 1998, Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin, J Clin Invest, 102, 764, 10.1172/JCI942 Sato, 2007, Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea, Biochem Biophys Res Commun, 362, 793, 10.1016/j.bbrc.2007.06.130 Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu Rev Physiol, 72, 219, 10.1146/annurev-physiol-021909-135846 Yoshimura, 1997, Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells, Pharmacology, 54, 144, 10.1159/000139481 Scott-Conner, 1994, The pathophysiology of biliary obstruction and its effect on phagocytic and immune function, J Surg Res, 57, 316, 10.1006/jsre.1994.1151 Hov, 2010, Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis, PLoS One, 5, e12403, 10.1371/journal.pone.0012403 Baffy, 2009, Kupffer cells in non-alcoholic fatty liver disease: the emerging view, J Hepatol, 51, 212, 10.1016/j.jhep.2009.03.008 Grundy, 1971, Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism, J Lab Clin Med, 78, 94 Nestel, 1976, Changes in cholesterol synthesis and excretion when cholesterol intake is increased, Metabolism, 25, 1591, 10.1016/0026-0495(76)90112-8 Angelin, 1978, Effect of cholestyramine on bile acid kinetics in patients with portal cirrhosis of the liver. Evidence of a selective defect in the formation of cholic acid, Am J Dig Dis, 23, 1115, 10.1007/BF01072887 Glicksman, 2010, Postprandial plasma bile acid responses in normal weight and obese subjects, Ann Clin Biochem, 10.1258/acb.2010.010040 Kobayashi, 2007, Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin, Diabetes, 56, 239, 10.2337/db06-0353 Yamakawa, 2007, Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia, Endocr J, 54, 53, 10.1507/endocrj.K05-098 Fonseca, 2008, Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy, Diabetes Care, 31, 1479, 10.2337/dc08-0283 Mussig, 2009, Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus, Metabolism, 58, 1809, 10.1016/j.metabol.2009.06.012 Pellicciari, 2007, Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5, J Med Chem, 50, 4265, 10.1021/jm070633p Macchiarulo, 2008, Molecular field analysis and 3D-quantitative structure–activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5, J Chem Inf Model, 48, 1792, 10.1021/ci800196h Pellicciari, 2009, Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity, J Med Chem, 52, 7958, 10.1021/jm901390p Sato, 2008, Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure–activity relationships, and molecular modeling studies, J Med Chem, 51, 1831, 10.1021/jm7015864 Genet, 2010, Structure–activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes, J Med Chem, 53, 178, 10.1021/jm900872z Genet, 2010, Redefining the TGR5 triterpenoid binding pocket at the C-3 position, ChemMedChem, 5, 1983, 10.1002/cmdc.201000329 Keitel, 2010, The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain, Glia, 58, 1794, 10.1002/glia.21049 Evans, 2009, Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists, J Med Chem, 52, 7962, 10.1021/jm901434t Yang, 2007, Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes, Biochem Biophys Res Commun, 361, 156, 10.1016/j.bbrc.2007.07.001 Yasuda, 2007, Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells, Biochem Biophys Res Commun, 354, 154, 10.1016/j.bbrc.2006.12.168 Desai, 2010, Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis, Hepatology, 51, 2097, 10.1002/hep.23585 Perides, 2010, Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1, Gastroenterology, 138, 715, 10.1053/j.gastro.2009.10.052 Motola, 2006, Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans, Cell, 124, 1209, 10.1016/j.cell.2006.01.037 Gerisch, 2007, A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling, Proc Natl Acad Sci USA, 104, 5014, 10.1073/pnas.0700847104 Houtkooper, 2010, Metabolic networks of longevity, Cell, 142, 9, 10.1016/j.cell.2010.06.029